Omeros Corporation [NASDAQ: OMER] traded at a high on 12/01/20, posting a 8.54 gain after which it closed the day’ session at $12.58. The company report on November 18, 2020 that Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA.
— Priority Review Requested –.
Omeros Corporation (Nasdaq: OMER) announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Narsoplimab targets mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the lectin pathway of complement, and has received breakthrough therapy designation and orphan drug designation from FDA for HSCT-TMA.
The results of the trading session contributed to over 2332606 shares changing hands. Over the past one week, the price volatility of Omeros Corporation stands at 6.30% while the volatility over the past one month is 5.91%.
The market cap for OMER stock reached $773.54 million, with 58.23 million shares outstanding and 53.76 million shares in the current float. Compared to the average trading volume of 966.42K shares, OMER reached a trading volume of 2332606 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Omeros Corporation [OMER]?
BofA Securities have made an estimate for Omeros Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 20, 2020. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $34 to $32. The new note on the price target was released on August 21, 2020, representing the official price target for Omeros Corporation stock. Previously, the target price had yet another drop from $25 to $20, while Maxim Group kept a Buy rating on OMER stock.
The Average True Range (ATR) for Omeros Corporation is set at 0.65, with the Price to Sales ratio for OMER stock in the period of the last 12 months amounting to 8.01.
How has OMER stock performed recently?
Omeros Corporation [OMER] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.45. With this latest performance, OMER shares gained by 24.06% in over the last four-week period, additionally sinking by -15.85% over the last 6 months – not to mention a drop of -12.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OMER stock in for the last two-week period is set at 65.02, with the RSI for the last a single of trading hit 68.79, and the three-weeks RSI is set at 59.52 for Omeros Corporation [OMER]. The present Moving Average for the last 50 days of trading for this stock 10.96, while it was recorded at 11.80 for the last single week of trading, and 13.20 for the last 200 days.
Omeros Corporation [OMER]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Omeros Corporation [OMER] shares currently have an operating margin of -56.69 and a Gross Margin at +97.63. Omeros Corporation’s Net Margin is presently recorded at -75.57.
Return on Total Capital for OMER is now -93.00, given the latest momentum, and Return on Invested Capital for the company is -128.09. Additionally, OMER Total Debt to Total Capital is recorded at 228.24, with Total Debt to Total Assets ending up at 141.66.
Reflecting on the efficiency of the workforce at the company, Omeros Corporation [OMER] managed to generate an average of -$327,465 per employee. Receivables Turnover for the company is 3.86 with a Total Asset Turnover recorded at a value of 0.96.Omeros Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.10 and a Current Ratio set at 4.10.
Earnings analysis for Omeros Corporation [OMER]
With the latest financial reports released by the company, Omeros Corporation posted -0.58/share EPS, while the average EPS was predicted by analysts to be reported at -0.5/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -16.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OMER.
Insider trade positions for Omeros Corporation [OMER]
There are presently around $439 million, or 57.40% of OMER stock, in the hands of institutional investors. The top three institutional holders of OMER stocks are: CORMORANT ASSET MANAGEMENT, LP with ownership of 5,000,000, which is approximately 80.18% of the company’s market cap and around 4.41% of the total institutional ownership; BLACKROCK INC., holding 4,888,205 shares of the stock with an approximate value of $61.49 million in OMER stocks shares; and INGALLS & SNYDER LLC, currently with $55.52 million in OMER stock with ownership of nearly -0.555% of the company’s market capitalization.
Positions in Omeros Corporation stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 91 institutional holders increased their position in Omeros Corporation [NASDAQ:OMER] by around 8,319,573 shares. Additionally, 42 investors decreased positions by around 5,219,576 shares, while 23 investors held positions by with 21,375,857 shares. The mentioned changes placed institutional holdings at 34,915,006 shares, according to the latest SEC report filing. OMER stock had 32 new institutional investments in for a total of 2,537,916 shares, while 19 institutional investors sold positions of 796,906 shares during the same period.